3 Stocks Worth Buying at 52-Week Lows

Key Points

  • Stocks that are trading at their 52-week lows can be good candidates for value investors. 
  • Keurig Dr Pepper (KDP) is holding its own in the competitive beverage market.  
  • Pfizer (PFE) has a long-term growth story that goes beyond noisy headlines. 
  • Analysts still like CVS Health (CVS) with recent price targets that remain above consensus.  
  • 5 stocks we like better than Keurig Dr Pepper

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in Keurig Dr Pepper right now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Keurig Dr Pepper (KDP)
4.0779 of 5 stars
$33.84+4.6%2.54%21.83Moderate Buy$36.45
Monster Beverage (MNST)
4.3082 of 5 stars
$53.15-2.2%N/A34.29Moderate Buy$61.79
Pfizer (PFE)
4.9782 of 5 stars
$25.26-3.8%6.65%70.17Hold$36.33
Seagen (SGEN)
0.3127 of 5 stars
$228.74flatN/A-57.04Hold$229.00
Amgen (AMGN)
4.9231 of 5 stars
$269.38-1.3%3.34%21.57Moderate Buy$296.95
Horizon Therapeutics Public (HZNP)
0 of 5 stars
$116.30flatN/A62.19HoldN/A
CVS Health (CVS)
5 of 5 stars
$67.32-0.7%3.95%10.42Moderate Buy$89.44
Compare These Stocks  Add These Stocks to My Watchlist 

Chris Markoch

About Chris Markoch

  • CTMarkoch@msn.com

Editor & Contributing Author

Retirement, Individual Investing

Experience

Chris Markoch has been an editor & contributing writer for MarketBeat since 2018.

Areas of Expertise

Value investing, retirement stocks, dividend stocks

Education

Bachelor of Arts, The University of Akron

Past Experience

InvestorPlace


Featured Articles and Offers

5 Hottest CEO Stock Purchases

5 Hottest CEO Stock Purchases

No insider is more significant than the CEO. This is a list of the five most significant CEO purchases in Q1 2024 based on dollar volume.

Search Headlines: